R
Robert L. Carithers
Researcher at University of Washington
Publications - 104
Citations - 8540
Robert L. Carithers is an academic researcher from University of Washington. The author has contributed to research in topics: Liver transplantation & Hepatitis C virus. The author has an hindex of 47, co-authored 104 publications receiving 8139 citations. Previous affiliations of Robert L. Carithers include Virginia Commonwealth University & Novartis.
Papers
More filters
Journal ArticleDOI
AASLD practice guidelines: Evaluation of the patient for liver transplantation
TL;DR: Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case.
Journal ArticleDOI
Fulminant Hepatic Failure: Summary of a Workshop
TL;DR: There are no specific therapies for FHF, however, liver transplantation is recommended for situations in which spontaneous recovery appears unlikely and a suitable liver graft is available for transplantation.
Journal ArticleDOI
Methylprednisolone Therapy in Patients with Severe Alcoholic Hepatitis: A Randomized Multicenter Trial
Robert L. Carithers,H. Franklin Herlong,Anna Mae Diehl,Ellen W. Shaw,Burton Combes,Harold J. Fallon,Willis C. Maddrey +6 more
TL;DR: In this paper, a randomized, double-blind, placebo-controlled multicenter trial was conducted to determine the efficacy of a corticosteroid in reducing the short-term mortality of patients with severe alcoholic hepatitis.
Journal ArticleDOI
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data
Philippe Mathurin,John O'Grady,Robert L. Carithers,Martin Phillips,Alexandre Louvet,Charles L. Mendenhall,Marie José Ramond,Sylvie Naveau,Willis C. Maddrey,Timothy R. Morgan +9 more
TL;DR: Analysis of individual data from five RCTs showed that corticosteroids significantly improve 28-day survival in patients with severe alcoholic hepatitis, mainly observed in patients classified as responders by the Lille model.
Journal ArticleDOI
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
Philippe Mathurin,Charles L. Mendenhall,Robert L. Carithers,Marie José Ramond,Willis C. Maddrey,Peter Garstide,Bernard Rueff,Sylvie Naveau,Jean Claude Chaput,Thierry Poynard +9 more
TL;DR: Corticosteroids improved short-term survival of patients with severe AH and age and serum creatinine are independent prognostic factors.